Cargando…

Camostat mesilate therapy for COVID-19

Detalles Bibliográficos
Autor principal:	Uno, Yoshiharu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2020
Materias:	Ce - Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7188520/ https://www.ncbi.nlm.nih.gov/pubmed/32347443 http://dx.doi.org/10.1007/s11739-020-02345-9

Ejemplares similares

Acute eosinophilic pneumonia caused by camostat mesilate: The first case report
por: Ota, Shinichiro, et al.
Publicado: (2016)

Efficacy of the TMPRSS2 inhibitor camostat mesilate in patients hospitalized with Covid-19-a double-blind randomized controlled trial.
por: Gunst, Jesper D., et al.
Publicado: (2021)

Camostat mesylate therapy in critically ill patients with COVID-19 pneumonia
por: Sakr, Yasser, et al.
Publicado: (2021)

Ethics in the age of COVID-19
por: Arora, Ananya, et al.
Publicado: (2020)

COVID-19: thoughts at sunrise
por: Gasbarrini, Giovanni
Publicado: (2020)

COVID-19 vaccines and thrombosis
por: Famularo, Giuseppe
Publicado: (2021)

Simultaneous Treatment of COVID-19 With Serine Protease Inhibitor Camostat and/or Cathepsin L Inhibitor?
por: Bittmann, Stefan, et al.
Publicado: (2020)

COVID-19 and elderly: beyond the respiratory drama
por: Sciacqua, Angela, et al.
Publicado: (2020)

COVID-19: in the uncertainty, do not try this at home
por: Lupia, Tommaso, et al.
Publicado: (2020)

COVID-19: a clinical and organizational crisis
por: Russo, Emanuele, et al.
Publicado: (2020)

Should the search for COVID-19 become part of the work-up of incidental thromboembolism? A near-missed COVID-19 diagnosis
por: Franceschini, Marta, et al.
Publicado: (2020)

Atrial Fibrillation and Managed Care: Current Approaches and Future Directions for Long-Term Therapy
por: Sanoski, Cynthia A., et al.
Publicado: (2009)

Central neurological complications and potential neuropathogenesis of COVID-19
por: Wang, Jianing, et al.
Publicado: (2020)

COVID-19 and asplenia: a Janus-faced issue
por: Lenti, Marco Vincenzo, et al.
Publicado: (2021)

Telemedicine in the acute care setting during the COVID-19 pandemic
por: Lin, Ziwei, et al.
Publicado: (2020)

Role of doctors in epidemics: historical perspectives and implications for COVID-19
por: Lippi, Donatella, et al.
Publicado: (2020)

Antagonizing the renin–angiotensin–aldosterone system in the era of COVID-19
por: Sarzani, Riccardo, et al.
Publicado: (2020)

High-dose steroids for the treatment of severe COVID-19: comment
por: Tanaka, Shuichi, et al.
Publicado: (2021)

Communication and relationship at time of COVID-19: a possible heritage
por: Vegni, Elena, et al.
Publicado: (2022)

Delirium in COVID‑19 pneumonia: looking inside the geriatric unit
por: Vargas, Nicolas, et al.
Publicado: (2022)

Fibrosis‑4 (FIB‑4) index and mortality in COVID‑19 patients admitted to the emergency department: a new interesting predictive index for patients with COVID-19 disease?
por: Ruggeri, Paolo, et al.
Publicado: (2022)

Triage decision-making at the time of COVID-19 infection: the Piacenza strategy
por: Erika, Poggiali, et al.
Publicado: (2020)

Delirium in COVID‑19 pneumonia: looking inside the geriatric unit—reply
por: Callea, Antonio, et al.
Publicado: (2022)

Lung ultrasound presentation of covid-19 patients: phenotypes and correlations—comment
por: Nekludova, Galina, et al.
Publicado: (2021)

The burden of thrombotic complications in critically ill patients with COVID-19: charting the uncharted
por: Landi, Antonio, et al.
Publicado: (2020)

COVID-19, coagulopathy and venous thromboembolism: more questions than answers—comment
por: Ponzetto, Antonio, et al.
Publicado: (2020)

Two different patterns of lymphocyte alterations in critically ill COVID-19 patients
por: Lafarge, Antoine, et al.
Publicado: (2021)

COVID-19 and related symptoms in patients under disulfiram for alcohol use disorder
por: Tamburin, Stefano, et al.
Publicado: (2021)

Immune thrombocytopenia following COVID-19 mRNA vaccine: casuality or causality?
por: Pasin, Federico, et al.
Publicado: (2021)

Oxygen–ozone treatment and COVID-19: antioxidants targeting endothelia lead the scenery
por: Varesi, Angelica, et al.
Publicado: (2021)

Incidence and outcome of delirium during helmet CPAP treatment in COVID-19 patients
por: Samartin, Federica, et al.
Publicado: (2021)

Procalcitonin for the differential diagnosis of COVID-19 in the emergency department. Prospective monocentric study
por: Nazerian, Peiman, et al.
Publicado: (2021)

Managing anticoagulation in the COVID-19 era between lockdown and reopening phases: Comment
por: Magon, Arianna, et al.
Publicado: (2021)

Large-vessel vasculitis following the Pfizer-BioNTech COVID-19 vaccine
por: Gilio, Michele, et al.
Publicado: (2022)

Medical professionalism in times of COVID-19 pandemic: is economic logic trumping medical ethics?
por: Ćurković, Marko, et al.
Publicado: (2020)

“Large-vessel vasculitis following the Pfizer-BioNTech COVID-19 vaccine”: comment
por: Sookaromdee, Pathum, et al.
Publicado: (2022)

Two-years chest-CT follow-up after severe COVID-19 pneumonia
por: Flor, Nicola, et al.
Publicado: (2023)

COVID-19 pandemic and Internal Medicine Units in Italy: a precious effort on the front line
por: Montagnani, Andrea, et al.
Publicado: (2020)

Are we on brink of a second COVID-19 wave in Italy? Let’s look at Google Trends
por: Ciaffi, Jacopo, et al.
Publicado: (2020)

Bilateral lower limb weakness: a cerebrovascular consequence of covid-19 or a complication associated with it?
por: Morjaria, J. B., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_je63vnk8maq9bmbn8e80etjsu7